Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass

Annals of Thoracic Surgery

Volumn 68, Issue 5, 1999, Pages 1661-1667

  Hayashida, Nobuhiko ^a   Tomoeda, Hiroshi ^a   Oda, Takeshi ^a   Tayama, Eiki ^a   Chihara, Shingo ^a   Kawara, Takemi ^a   Aoyagi, Shigeaki ^a  

^a KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; C REACTIVE PROTEIN; CREATINE KINASE MB; CYCLIC AMP; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MILRINONE; PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; BLOOD LEVEL; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; CORONARY ARTERY BYPASS; CREATINE KINASE; CYCLIC AMP; CYTOKINES; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; ISOENZYMES; MALE; MIDDLE AGED; MILRINONE; PHOSPHODIESTERASE INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0032754082     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00716-X     Document Type: Conference Paper

References (27)

1. Butler J., Rocker G.M., Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 55:1993;552-559.
2. Hennein H.A., Ebba H., Rodriguez J.L., et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg. 108:1994;626-635.
3. Wan S., DeSmet J.M., Barvais L., Goldstein M., Vincent J.L., LeClerc J.L. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 112:1996;806-811.
4. Casey L.C. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg. 56:1993;S92-S96.
5. Konstam M.A., Cody R.J. Short-term use of intravenous milrinone for heart failure. Am J Cardiol. 75:1995;822-826.
6. Wright E.M., Sherry K.M. Clinical and haemodynamic effects of milrinone in the treatment of low cardiac output after cardiac surgery. Br J Anaesthesia. 67:1991;585-590.
7. Molnar-Kimber K., Yonno L., Heaslip R., Weichman B. Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors. Agents Action. 39:1993;C77-C79.
8. Yoshimura T., Usami E., Kurita C., et al. Effect of theophylline on the production of interleukin-1, tumor necrosis factor-α, and interleukin-8 by human peripheral blood mononuclear cells. Biol Pharmacol Bull. 18:1995;1405-1408.
9. Bergman M.R., Holycross B.J. Pharmacological modulation of myocardial tumor necrosis factor α production by phosphodiesterase inhibitors. J Pharmacol Exp Ther. 279:1996;247-254.
10. Yoshimura T., Kurita C., Nagao T., et al. Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Gen Pharmacol. 29:1997;633-638.
11. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
12. Monrad E.S., Baim D.S., Smith H.S., Lanoue A.S. Milrinone, dobutamine, and nitroprusside comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure . Circulation. 73:(suppl 3):1986;168-174.
13. Imai S., Katano Y., Nakazawa M., Shimamoto N. The effects of norepinephrine on the release of cyclic AMP by the isolated perfused heart of the Guinea pig. Life Sci. 23:1978;1609-1618.
14. Semmler J., Gebert U., Eisenhut T., Moeller J., Schönharting M.M., Alléra A. Xanthine derivatives comparison between suppression of tumour necrosis factor-α production and inhibition of cAMP phosphodiesterase activity . Immunology. 78:1993;520-525.
15. Endres S., Fülle H.J., Sinha B., et al. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-α and interleukin-1β by human mononuclear cells. Immunology. 72:1991;56-60.
16. Viherluoto J., Palkama T., Silvennoinen O., Hurme M. Cyclic adenosine monophosphate decreases the secretion, but not the cell-associated levels, of interleukin-1β in lipopolysaccharide-activated human monocytes. Scand J Immunol. 34:1991;121-125.
17. Verghese M.W., McConnell R.T., Strickland A.B., et al. Differential regulation of human monocyte-derived TNFα and IL-1β by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J Pharmacol Exp Ther. 272:1995;1313-1320.
18. Bailly S., Ferrua B., Fay M., Gougerot-Pocidalo M.A. Differential regulation of IL 6, IL 1A, IL 1β and TNFα production in LPS-stimulated human monocytes role of cyclic AMP . Cytokine. 2:1990;205-210.
19. Zabel P., Wolter D.T., Schönharting M.M., Schade U.F. Oxpentifylline in endotoxaemia. Lancet. 2:1989;1474-1477.
20. Matsumori A., Shioi T., Yamada T., Matsui S., Sasayama S. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation. 89:1994;955-958.
21. Yamauchi-Takihara K., Ihara Y., Ogata A., Yoshizaki K., Azuma J., Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 91:1995;1520-1524.
22. Chang-Chun C., Matsuda H., Sawa Y., et al. Effect of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury. Ann Thorac Surg. 52:1991;495-499.
23. Larsen C.G., Anderson A.O., Oppenheim J.J., Matsushima K. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology. 68:1989;31-36.
24. Hayashida N., Isomura T., Sato T., Maruyama H., Kosuga K., Aoyagi S. Effects of minimal-dose aprotinin on coronary artery bypass grafting. J Thorac Cardiovasc Surg. 114:1997;261-269.
25. Hill G.E., Alonso A., Spurzem J.R., Stammers A.H., Robbins R.A. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg. 110:1995;1658-1662.
26. Seghaye M.C., Duchateau J., Grabitz R.G., et al. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg. 61:1996;1205-1211.
27. Ashraf S., Tian Y., Cowan D., et al. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. Ann Thorac Surg. 63:1997;68-73.